PROCTER & GAMBLE HEALTH | GUFIC BIOSCIENCE | PROCTER & GAMBLE HEALTH/ GUFIC BIOSCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 37.7 | 91.7% | View Chart |
P/BV | x | 10.6 | 9.1 | 115.5% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | 6,589.5% |
PROCTER & GAMBLE HEALTH GUFIC BIOSCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
GUFIC BIOSCIENCE Mar-23 |
PROCTER & GAMBLE HEALTH/ GUFIC BIOSCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 290 | 1,853.1% | |
Low | Rs | 3,883 | 177 | 2,192.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 71.2 | 1,039.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 8.2 | 1,681.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 10.5 | 1,474.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.10 | 95,000.0% | |
Avg Dividend yield | % | 2.1 | 0 | 4,793.3% | |
Book value per share (Unadj.) | Rs | 447.6 | 35.9 | 1,247.6% | |
Shares outstanding (eoy) | m | 16.60 | 96.94 | 17.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.3 | 190.6% | |
Avg P/E ratio | x | 33.5 | 28.4 | 117.9% | |
P/CF ratio (eoy) | x | 29.8 | 22.2 | 134.4% | |
Price / Book Value ratio | x | 10.3 | 6.5 | 158.8% | |
Dividend payout | % | 68.7 | 1.2 | 5,650.0% | |
Avg Mkt Cap | Rs m | 76,761 | 22,620 | 339.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 867 | 237.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 6,906 | 178.0% | |
Other income | Rs m | 184 | 26 | 714.5% | |
Total revenues | Rs m | 12,480 | 6,932 | 180.0% | |
Gross profit | Rs m | 3,247 | 1,347 | 241.1% | |
Depreciation | Rs m | 281 | 223 | 126.1% | |
Interest | Rs m | 8 | 82 | 9.4% | |
Profit before tax | Rs m | 3,142 | 1,067 | 294.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 270 | 313.6% | |
Profit after tax | Rs m | 2,295 | 797 | 287.9% | |
Gross profit margin | % | 26.4 | 19.5 | 135.4% | |
Effective tax rate | % | 27.0 | 25.3 | 106.5% | |
Net profit margin | % | 18.7 | 11.5 | 161.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 4,641 | 252.4% | |
Current liabilities | Rs m | 6,791 | 2,882 | 235.6% | |
Net working cap to sales | % | 40.0 | 25.5 | 157.2% | |
Current ratio | x | 1.7 | 1.6 | 107.1% | |
Inventory Days | Days | 263 | 35 | 742.9% | |
Debtors Days | Days | 343 | 1,086 | 31.6% | |
Net fixed assets | Rs m | 10,617 | 3,961 | 268.0% | |
Share capital | Rs m | 166 | 97 | 171.2% | |
"Free" reserves | Rs m | 7,265 | 3,381 | 214.9% | |
Net worth | Rs m | 7,431 | 3,478 | 213.6% | |
Long term debt | Rs m | 0 | 1,907 | 0.0% | |
Total assets | Rs m | 22,330 | 8,602 | 259.6% | |
Interest coverage | x | 409.1 | 14.0 | 2,926.3% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 68.6% | |
Return on assets | % | 10.3 | 10.2 | 100.9% | |
Return on equity | % | 30.9 | 22.9 | 134.8% | |
Return on capital | % | 42.4 | 21.3 | 198.6% | |
Exports to sales | % | 0 | 12.5 | 0.0% | |
Imports to sales | % | 13.1 | 39.3 | 33.2% | |
Exports (fob) | Rs m | NA | 860 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 2,716 | 59.1% | |
Fx inflow | Rs m | 1,465 | 860 | 170.3% | |
Fx outflow | Rs m | 1,605 | 2,716 | 59.1% | |
Net fx | Rs m | -140 | -1,855 | 7.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -266 | -887.7% | |
From Investments | Rs m | -215 | -1,907 | 11.3% | |
From Financial Activity | Rs m | -985 | 2,343 | -42.0% | |
Net Cashflow | Rs m | 1,160 | 170 | 682.8% |
Indian Promoters | % | 0.0 | 72.5 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 2.3 | 860.8% | |
FIIs | % | 6.2 | 0.1 | 5,200.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 27.5 | 175.3% | |
Shareholders | 56,778 | 34,695 | 163.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | GUFIC BIOSCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 2.82% | 0.45% |
1-Month | -1.15% | 12.53% | 2.55% |
1-Year | 0.73% | 63.93% | 56.14% |
3-Year CAGR | -8.76% | 33.40% | 15.22% |
5-Year CAGR | 4.97% | 31.81% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the GUFIC BIOSCIENCE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of GUFIC BIOSCIENCE the stake stands at 72.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of GUFIC BIOSCIENCE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
GUFIC BIOSCIENCE paid Rs 0.1, and its dividend payout ratio stood at 1.2%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of GUFIC BIOSCIENCE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.